Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevance (Q36273357)

13 August 2017

1 reference

title

Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevance (English)

1 reference

13 August 2017

Tom Teerlink

1

1 reference

13 August 2017

1 January 2005

1 reference

Clinical Chemistry and Laboratory Medicine

13 August 2017

1 reference

13 August 2017

43

1 reference

13 August 2017

10

1 reference

13 August 2017

1130-1138

1 reference

Homocysteine effect on protein degradation rates

13 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

Relationship between S-adenosylmethionine, S-adenosylhomocysteine, asymmetric dimethylarginine, and endothelial function in healthy human subjects during experimental hyper- and hypohomocysteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

Liquid chromatography-tandem mass spectrometry method for the analysis of asymmetric dimethylarginine in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure--possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

Association of asymmetric dimethylarginine and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

Determination of arginine and asymmetric dimethylarginine (ADMA) in human plasma by liquid chromatography/mass spectrometry with the isotope dilution technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

Homocyst(e)ine-lowering therapy does not affect plasma asymmetrical dimethylarginine concentrations in patients with peripheral artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

HPLC-tandem mass spectrometric method for rapid quantification of dimethylarginines in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

ADMA and hyperhomocysteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

Nitric oxide synthase: role in the genesis of vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

ADMA metabolism and clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

Does ADMA cause endothelial dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

Hyperhomocysteinaemia is not associated with increased levels of asymmetric dimethylarginine in patients with ischaemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

Effect of hormone replacement therapy on plasma levels of the cardiovascular risk factor asymmetric dimethylarginine: a randomized, placebo-controlled 12-week study in healthy early postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

A proteomic analysis of arginine-methylated protein complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

Quantification of ADMA: analytical approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

Prevalence and determinants of glucose intolerance in a Dutch caucasian population. The Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

Asymmetric dimethylarginine and total homocysteine in plasma after oral methionine loading

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

Capillary electrophoretic and micellar electrokinetic separations of asymmetric dimethyl-L-arginine and structurally related amino acids: quantitation in human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.197

21 January 2018

Identifiers

DOI

10.1515/CCLM.2005.197

1 reference

13 August 2017

1 reference

PubMed ID

16197310